Artwork

Content provided by Congress of Neurological Surgeons Podcasts and Congress of Neurological Surgeons. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Congress of Neurological Surgeons Podcasts and Congress of Neurological Surgeons or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

CNS Guidelines Podcast - Brain Metastases Emerging Therapies Update - Immunotherapy

24:39
 
Share
 

Manage episode 472306151 series 1548333
Content provided by Congress of Neurological Surgeons Podcasts and Congress of Neurological Surgeons. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Congress of Neurological Surgeons Podcasts and Congress of Neurological Surgeons or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Patients with metastatic brain tumors (MBTs) require a multidisciplinary team-based approach to select the best treatment interventions. This podcast updates recommendations that address whether treatment with immune modulators benefits patients with parenchymal or leptomeningeal brain metastases in terms of local control, OS, PFS, performance status, or reduction in CNS side effects compared with standard management with chemotherapy, molecular targeted agents, SRS, WBRT, and surgical resection. J. Bradley Elder, MD Jeffrey J. Olson, MD D. Ryan Ormond, MD, Phd
  continue reading

158 episodes

Artwork
iconShare
 
Manage episode 472306151 series 1548333
Content provided by Congress of Neurological Surgeons Podcasts and Congress of Neurological Surgeons. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Congress of Neurological Surgeons Podcasts and Congress of Neurological Surgeons or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Patients with metastatic brain tumors (MBTs) require a multidisciplinary team-based approach to select the best treatment interventions. This podcast updates recommendations that address whether treatment with immune modulators benefits patients with parenchymal or leptomeningeal brain metastases in terms of local control, OS, PFS, performance status, or reduction in CNS side effects compared with standard management with chemotherapy, molecular targeted agents, SRS, WBRT, and surgical resection. J. Bradley Elder, MD Jeffrey J. Olson, MD D. Ryan Ormond, MD, Phd
  continue reading

158 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play